Jenburkt Pharmaceuticals Ltd
BSE:524731
Jenburkt Pharmaceuticals Ltd
Other Long-Term Assets
Jenburkt Pharmaceuticals Ltd
Other Long-Term Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Jenburkt Pharmaceuticals Ltd
BSE:524731
|
Other Long-Term Assets
â‚ą303.4m
|
CAGR 3-Years
514%
|
CAGR 5-Years
135%
|
CAGR 10-Years
N/A
|
||
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Other Long-Term Assets
â‚ą18.6B
|
CAGR 3-Years
24%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
||
Cipla Ltd
NSE:CIPLA
|
Other Long-Term Assets
â‚ą8.3B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
2%
|
CAGR 10-Years
19%
|
||
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Other Long-Term Assets
â‚ą46.8B
|
CAGR 3-Years
11%
|
CAGR 5-Years
4%
|
CAGR 10-Years
13%
|
||
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Other Long-Term Assets
â‚ą6.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
7%
|
CAGR 10-Years
15%
|
|
M
|
Mankind Pharma Ltd
NSE:MANKIND
|
Other Long-Term Assets
â‚ą1.1B
|
CAGR 3-Years
26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Jenburkt Pharmaceuticals Ltd
Glance View
Jenburkt Pharmaceuticals Ltd. engages in the manufacture and marketing of pharmaceutical formulations and healthcare products. The company is headquartered in Mumbai, Maharashtra and currently employs 730 full-time employees. The firm offers pharmaceutical products for various therapeutic areas, analgesic and antipyretics anthelmintics, anti-arthritic, anti-diabetics, anti-infectives, antifungals, antimalarials, antiulcerants/antacids, aphrodisiac, consumer division, cough and cold, muscle relaxants neuropathic pain, nutraceuticals and pain management. The firm's product brands include Allerzine tablets, Cartisafe forte MSM tablets, Eberjen Cream and SOL, ECOPROT powder, Frendacid suspension, Fundu tablets, Glajen-E capsules, GLUCOTROL tablets, Jenflam tablets, Lutriben cream, Ornel tablets, Pantazole tablets and others. The firm's manufacturing plant is located in Sihor-Gujarat. The firm's products are exported to approximately 13 countries globally.
See Also
What is Jenburkt Pharmaceuticals Ltd's Other Long-Term Assets?
Other Long-Term Assets
303.4m
INR
Based on the financial report for Sep 30, 2024, Jenburkt Pharmaceuticals Ltd's Other Long-Term Assets amounts to 303.4m INR.
What is Jenburkt Pharmaceuticals Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
135%
Over the last year, the Other Long-Term Assets growth was 41%. The average annual Other Long-Term Assets growth rates for Jenburkt Pharmaceuticals Ltd have been 514% over the past three years , 135% over the past five years .